Found 15 bookmarks
Custom sorting
Diversity of Circulating Clostridioides difficile Ribotypes in Mexico and Susceptibility to Fidaxomicin, Vancomycin, and Metronidazole
Diversity of Circulating Clostridioides difficile Ribotypes in Mexico and Susceptibility to Fidaxomicin, Vancomycin, and Metronidazole
In this study, we report the results of the epidemiological analysis of Clostridioides difficile ribotypes (RTs) and antimicrobial susceptibility testing. Most isolates were RT027, representing 73% (84/115) of isolates. No isolates with reduced susceptibility to fidaxomicin were found; howeve …
·pubmed.ncbi.nlm.nih.gov·
Diversity of Circulating Clostridioides difficile Ribotypes in Mexico and Susceptibility to Fidaxomicin, Vancomycin, and Metronidazole
Proteomic Adaptation of Clostridioides difficile to Treatment with the Antimicrobial Peptide Nisin
Proteomic Adaptation of Clostridioides difficile to Treatment with the Antimicrobial Peptide Nisin
Clostridioides difficile is the leading cause of antibiotic-associated diarrhea but can also result in more serious, life-threatening conditions. The incidence of C. difficile infections in hospitals is increasing, both in frequency and severity, and antibiotic-resistant C. difficil …
·pubmed.ncbi.nlm.nih.gov·
Proteomic Adaptation of Clostridioides difficile to Treatment with the Antimicrobial Peptide Nisin
Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease
Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease
CDI may complicate the course of IBD, however the presentation may not be typical. Therefore, all patients with worsening gastrointestinal symptoms should be evaluated for both CDI and IBD exacerbation. Providers should consider FMT for all patients with recurrent CDI as well as escalation of immuno …
·pubmed.ncbi.nlm.nih.gov·
Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease
Study Recommends Vancomycin as First-Line Treatment for Patients with C. Diff Infection and Inflammatory Bowel Disease - Pharmacy Times
Study Recommends Vancomycin as First-Line Treatment for Patients with C. Diff Infection and Inflammatory Bowel Disease - Pharmacy Times
Further, while there is ambiguity surrounding the treatment of IBD flare in patients with CDI, case reports suggest corticosteroid initiation after appropriate antibiotic therapy may be effective.
·pharmacytimes.com·
Study Recommends Vancomycin as First-Line Treatment for Patients with C. Diff Infection and Inflammatory Bowel Disease - Pharmacy Times